Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- ASKA Licenses New Oral Formulation Technology from LINTEC
October 1, 2007
- Olympus to Launch Capsule Endoscope System in US
October 1, 2007
- Oncodesign Hosts Japanese Pharma Industry Group
October 1, 2007
- R&D NEWS IN BRIEF
October 1, 2007
- Environment to Allow Both Work and Childcare Needed to Retain Female MRs
October 1, 2007
- Feasibility Studies for Joint Clinical Trials in Asia Increasing: CMIC
October 1, 2007
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 1, 2007
- Chuikyo Members Favor Changes in Comparator Drug Selection Rule
October 1, 2007
- Mr Abe's Decision to Resign Sends Out Shockwave
September 24, 2007
- Disinfection in Boiling SDS Should Be Made Obligatory to Prevent Secondary Infection of CJD
September 24, 2007
- Korosho to Encourage Innovation While Optimizing Healthcare Expenditures: Mr Erikawa
September 24, 2007
- MEDICAL DEVICE NEWS IN BRIEF
September 24, 2007
- Benefits of Research Must Be Returned to the People: Mr Toguchi
September 24, 2007
- New Sales Strategy Going Extremely Well: Mr Kashiwagi of sanofi-aventis
September 24, 2007
- Breast Cancer Will Be One of the Major Topics in Women's Health Week: Mr Nishiyama
September 24, 2007
- AltaCare Provides Int. Sales, Business Dev. Services for Pharma, Consumer Care Products
September 24, 2007
- REGULATORY NEWS IN BRIEF
September 24, 2007
- Eli Lilly Enters GP Market with Cialis
September 24, 2007
- Boehringer Ingelheim to Initiate PIII Study for BIBW2992
September 24, 2007
- Taiyo Yakuhin's Outsourcing Study Group Focuses on Barrier Isolators
September 24, 2007
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…